Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-α induced gene expression

Benef Microbes. 2011 Jun;2(2):115-28. doi: 10.3920/BM2011.0005.

Abstract

To provide insight in the molecular basis for intestinal host-microbe interactions, we determined the genome-wide transcriptional response of human intestinal epithelial cells following exposure to cells of Bifidobacterium breve. To select an appropriate test system reflecting inflammatory conditions, the responsiveness to TNF-α was compared in T84, Caco-2 and HT-29 cells. The highest TNF-α response was observed in HT-29 cells and this cell line was selected for exposure to the B. breve strains M-16V, NR246 and UCC2003. After one hour of bacterial pre-incubation followed by two hours of additional TNF-α stimulation, B. breve M-16V (86%), but to a much lesser extent strains NR246 (50%) or UCC2003 (32%), showed a strain-specific reduction of the HT-29 transcriptional response to the inflammatory treatment. The most important functional groups of genes that were transcriptionally suppressed by the presence of B. breve M-16V, were found to be involved in immune regulation and apoptotic processes. About 54% of the TNF-α induced genes were solely suppressed by the presence of B. breve M-16V. These included apoptosis-related cysteine protease caspase 7 (CASP7), interferon regulatory factor 3 (IRF3), amyloid beta (A4) precursor proteinbinding family A member 1 (APBA1), NADPH oxidase (NOX5), and leukemia inhibitory factor receptor (LIFR). The extracellular IL-8 concentration was determined by an immunological assay but did not change significantly, indicating that B. breve M-16V only partially modulates the TNF-α pathway. In conclusion, this study shows that B. breve strains modulate gene expression in HT-29 cells under inflammatory conditions in a strain-specific way.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Bifidobacterium / physiology*
  • Cell Line
  • Down-Regulation / genetics
  • Epithelial Cells / physiology
  • Gene Expression / drug effects
  • Gene Expression / genetics*
  • HT29 Cells / immunology
  • HT29 Cells / microbiology*
  • HT29 Cells / pathology
  • Humans
  • Inflammation
  • Oligonucleotide Array Sequence Analysis
  • Pilot Projects
  • Probiotics
  • RNA, Bacterial / genetics
  • Species Specificity
  • Time Factors
  • Transcriptome
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • RNA, Bacterial
  • Tumor Necrosis Factor-alpha